Buscar
Mostrando ítems 21-30 de 306
Non-myogenic tumors display altered expression of dystrophin (DMD) and a high frequency of genetic alterations
(Impact Journals LLC, 2017-01)
DMD gene mutations have been associated with the development of Dystrophinopathies. Interestingly, it has been recently reported that DMD is involved in the development and progression of myogenic tumors, assigning DMD a ...
NOX2 Inhibition Restores Contractility, Intracellular Calcium Handling and Reduces Arrhythmogenicity in Dystrophic Cardiomyopathy
(LIPPINCOTT WILLIAMS & WILKINS, 2012)
Axonal sprouting in mdx mice and its relevance to cell and gene mediated therapies for Duchenne muscular dystrophy
(Elsevier Sci Ireland LtdClareIrlanda, 2003)
Combined therapies for Duchenne muscular dystrophy to optimize treatment efficacy
(Frontiers Media, 2018-04)
Duchene Muscular Dystrophy (DMD) is the most frequent muscular dystrophy and one of the most severe due to the absence of the dystrophin protein. Typical pathological features include muscle weakness, muscle wasting, ...
Quantitative changes of nicotinic receptors in the hippocampus of dystrophin-deficient mice
(Elsevier B.V., 2012-11-05)
Lack of dystrophin in Duchenne muscle dystrophy (DMD) and in the mutant mdx mouse results in progressive muscle degeneration, structural changes at the neuromuscular junction, and destabilization of the nicotinic acetylcholine ...